<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28487570</article-id><article-id pub-id-type="pmc">5431641</article-id><article-id pub-id-type="publisher-id">1907</article-id><article-id pub-id-type="doi">10.1038/s41598-017-01907-w</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kullmann</surname><given-names>Stephanie</given-names></name><address><email>stephanie.kullmann@med.uni-tuebingen.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Heni</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Veit</surname><given-names>Ralf</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Scheffler</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Machann</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>H&#x000e4;ring</surname><given-names>Hans-Ulrich</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fritsche</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8859-4661</contrib-id><name><surname>Preissl</surname><given-names>Hubert</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution/><institution>Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of T&#x000fc;bingen, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.452622.5</institution-id><institution/><institution>German Center for Diabetes Research (DZD e.V.), </institution></institution-wrap>T&#x000fc;bingen, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution>Institute of Medical Psychology and Behavioral Neurobiology, </institution><institution>University of T&#x000fc;bingen, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution>Department of Internal Medicine IV, </institution><institution>University of T&#x000fc;bingen, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2183 0052</institution-id><institution-id institution-id-type="GRID">grid.419501.8</institution-id><institution>Department of High-Field Magnetic Resonance, </institution><institution>Max Planck Institute for Biological Cybernetics, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution>Department of Biomedical Magnetic Resonance, </institution><institution>University of T&#x000fc;bingen, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution>Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum M&#x000fc;nchen, </institution><institution>German Research Center for Environmental Health (GmbH), </institution></institution-wrap>Neuherberg, Germany </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2190 1447</institution-id><institution-id institution-id-type="GRID">grid.10392.39</institution-id><institution>Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, </institution><institution>Eberhard Karls Universit&#x000e4;t T&#x000fc;bingen, </institution></institution-wrap>T&#x000fc;bingen, Germany </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>1627</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p>Brain insulin sensitivity is an important link between metabolism and cognitive dysfunction. Intranasal insulin is a promising tool to investigate central insulin action in humans. We evaluated the acute effects of 160 U intranasal insulin on resting-state brain functional connectivity in healthy young adults. Twenty-five lean and twenty-two overweight and obese participants underwent functional magnetic resonance imaging, on two separate days, before and after intranasal insulin or placebo application. Insulin compared to placebo administration resulted in increased functional connectivity between the prefrontal regions of the default-mode network and the hippocampus as well as the hypothalamus. The change in hippocampal functional connectivity significantly correlated with visceral adipose tissue and the change in subjective feeling of hunger after intranasal insulin. Mediation analysis revealed that the intranasal insulin induced hippocampal functional connectivity increase served as a mediator, suppressing the relationship between visceral adipose tissue and hunger. The insulin-induced hypothalamic functional connectivity change showed a significant interaction with peripheral insulin sensitivity. Only participants with high peripheral insulin sensitivity showed a boost in hypothalamic functional connectivity. Hence, brain insulin action may regulate eating behavior and facilitate weight loss by modifying brain functional connectivity within and between cognitive and homeostatic brain regions.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Interactions between the central and peripheral nervous system influence various metabolic and cognitive functions<sup><xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref></sup>. In this process, numerous hormonal signals play an important role to exert their effects on eating behavior and body weight<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Insulin is a major peripheral hormone released after food intake and the reduced ability of insulin to act on its target tissue, i.e. insulin resistance (IR), is a hallmark of type 2 diabetes mellitus (T2D) and obesity. Moreover, there is growing evidence that IR is an important link between metabolic diseases and deteriorating cognitive function<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref></sup>. While there is considerable evidence on the pathomechanisms of peripheral IR, central or brain IR is much less characterized in humans. It is clear meanwhile that insulin action in the brain goes beyond the homeostatic center (i.e. the hypothalamus) extending to other brain regions. To unravel the role of brain insulin action in humans, the intranasal approach is an efficient tool to deliver the peptide directly to the CNS compartment, practically bypassing the body periphery<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Neuroimaging revealed that intranasal insulin administration modulates brain networks involved in homeostatic control, reward processing, and cognitive control functions, thus, influencing different aspects of human behavior (for review see refs <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>). Furthermore, intranasal insulin produces multiple behavior and metabolic effects<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Acutely applied intranasal insulin decreases energy intake<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> and wanting for sweet foods<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. It intensifies satiety<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, modulates olfactory and gustatory sensitivity<sup><xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref></sup> and even improves peripheral insulin sensitivity<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. This is in line with animal studies confirming the central catabolic action of insulin (e.g. refs <xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>). Studies on cognitive effects indicate that hippocampal-dependent memory processes benefit particularly from intranasal insulin in humans<sup><xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref></sup>. Similarly, rodent studies have shown that insulin plays an important role in regulating synaptic plasticity in the hippocampus<sup><xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref></sup>. More recently, evidence accumulates that it is possible to improve cognitive functions in patients with T2D and early Alzheimer&#x02019;s disease by enhancing brain insulin action using intranasal insulin<sup><xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR27">27</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref></sup>. Furthermore, the observed improvement in cognitive functions in T2D patients is related to an increase in functional connectivity within the default-mode network (DMN), which is linked to higher cognitive functions as decision-making and memory<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. The DMN comprises a brain network exhibiting high functional connectivity between the frontal, lateral parietal cortices, precuneus and the temporal cortex including the hippocampus. Numerous studies have pointed to disruptions in functional connectivity within the DMN especially in neurological and neuropsychiatric disorders<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. However, also T2D and obesity are related to altered functional connectivity of the DMN preceding brain atrophy and cognitive impairment<sup><xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref></sup>. Furthermore, evidence has accumulated that, in cognitively healthy young overweight and obese humans, insulin resistance affects regions of the DMN<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Besides the hypothalamus, obesity-associated brain IR affects predominantly higher cognitive brain regions especially the prefrontal regions included in the DMN<sup><xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR39">39</xref></sup>. Furthermore, a recent study has shown that the central hubs of the DMN, the posterior cingulate cortex and medial prefrontal cortex, are functionally closely connected to the hypothalamus<sup><xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref></sup>. However, it is currently not clear whether it is possible to boost functional connectivity of the DMN in young overweight and obese brain insulin resistant individuals to improve their eating behavior and metabolism.</p><p>We hypothesize that intranasal insulin may acutely enhance signaling in the DMN and between the hypothalamus and the DMN in healthy young lean, overweight and obese adults. Furthermore, we hypothesize that this modification is related to peripheral metabolism and eating behavior. For this purpose, we acquired resting-state functional magnetic resonance imaging (fMRI) to measure functional connectivity of the brain in response to intranasal insulin and placebo administration.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><p>We evaluated insulin versus placebo-induced changes in functional connectivity in the DMN in lean, overweight and obese participants 30&#x02009;min after spray application. For this purpose, we used four different DMN seed regions for the analyses (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). This included the core regions and the prefrontal regions of the DMN, as the prefrontal cortex (PFC) is particular insulin responsive. The functional connectivity (FC) map of each network is shown in Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>. We additionally included a peripheral insulin sensitivity index, assessed by an oral glucose tolerance test on a separate day, as a covariate into the design. Hence, we were able to evaluate potential interactions between central and peripheral insulin sensitivity.</p><p>We observed a main effect of group (body weight) in the precuneus within the default-mode network (F&#x02009;=&#x02009;18.30; p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 whole-brain corrected; MNI coordinates x: 0 y: &#x02212;54 z: 60) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Overweight/obese compared to lean participants revealed increased FC between the posterior cingulate cortex and the precuneus on both insulin and placebo day.<fig id="Fig1"><label>Figure 1</label><caption><p>Change in functional connectivity in default-mode network (DMN) based on the posterior cingulate seed region after intranasal insulin (cyan) and placebo (gray) spray. Overweight and obese participants showed a stronger increase in precuneus functional connectivity (rs<italic>fMRI2</italic> minus rs<italic>fMRI1</italic>) on both insulin and placebo day compared to lean participants (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05, whole-brain corrected).</p></caption><graphic xlink:href="41598_2017_1907_Fig1_HTML" id="d29e482"/></fig>
</p><sec id="Sec3"><title>Insulin-induced changes in functional connectivity in the default-mode network</title><p>We observed a significant main effect of condition (insulin vs placebo) within the default-mode network, resulting in increased functional connectivity after intranasal insulin compared to placebo application in the hippocampus (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected). Specifically, insulin increased functional connectivity between the anterior medial PFC and the right hippocampus (F&#x02009;=&#x02009;13.85; p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected; MNI coordinates x: 33 y: &#x02212;27 z: &#x02212;9) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) and between the dorsal medial PFC and the right hippocampus (F&#x02009;=&#x02009;15.44; p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected; MNI coordinates x: 33 y: &#x02212;21 z: &#x02212;9) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). No significant group differences (body weight) were observed. Furthermore, we performed multiple regression analyses to investigate the relationship between the change in FC with hunger rating scores and different fat compartments. The change in FC between the dorsal medial PFC and the hippocampus significantly correlated with visceral adipose tissue (VAT) (T&#x02009;=&#x02009;3.9, p&#x02009;&#x0003c;&#x02009;0.001; r&#x02009;=&#x02009;0.496; r<sub>adj</sub>&#x02009;=&#x02009;0.529 adjusted for BMI, age, sex, and total intracranial volume (TICV)) and with the change in subjective feeling of hunger 120&#x02009;minutes after intranasal insulin spray application (T&#x02009;=&#x02009;&#x02212;3.6, p&#x02009;=&#x02009;0.001; r&#x02009;=&#x02009;&#x02212;0.476; r<sub>adj</sub>&#x02009;=&#x02009;&#x02212;0.504 adjusted for BMI, age, sex, and TICV). No such correlations were observed for change in FC between the anterior medial PFC and the hippocampus and on the placebo day.<fig id="Fig2"><label>Figure 2</label><caption><p>Intranasal insulin increased functional connectivity between the anterior medial prefrontal cortex (PFC) of the default-mode network (DMN) and the hippocampus in lean, overweight and obese participants. Group-averaged DMN of lean and overweight/obese participants under baseline condition (rs<italic>fMRI1</italic>) for the anterior medial PFC seed region is displayed in red (p&#x02009;&#x0003c;&#x02009;0.05, FWE whole-brain corrected). Cyan-color coded region reveals voxels within the right hippocampus showing a significant change in functional connectivity within the DMN based on the anterior medial PFC seed region after intranasal insulin compared to placebo (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected). Bar plot on right shows the change in functional connectivity after intranasal insulin and placebo (rs<italic>fMRI2</italic> minus rs<italic>fMRI1</italic>) between the anterior medial PFC and the hippocampus in lean, overweight and obese participants (i.e. the extracted differential correlation coefficients of the right hippocampus).</p></caption><graphic xlink:href="41598_2017_1907_Fig2_HTML" id="d29e531"/></fig>
<fig id="Fig3"><label>Figure 3</label><caption><p>Intranasal insulin increases functional connectivity between the dorsal medial prefrontal cortex (PFC) of the default-mode network (DMN) and the hippocampus in lean, overweight and obese participants. Group-averaged DMN of lean and overweight/obese participants under baseline condition (rs<italic>fMRI1</italic>) for the dorsal medial PFC seed region is displayed in dark green (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05, whole-brain corrected). Cyan-color coded region reveals voxels within the right hippocampus showing a significant change in functional connectivity within the DMN based on the dorsal medial PFC seed region after intranasal insulin compared to placebo (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected). Bar plot in the middle shows change in functional connectivity after intranasal insulin and placebo (rs<italic>fMRI2</italic> minus rs<italic>fMRI1</italic>) between the dorsal medial PFC and the hippocampus in lean, overweight and obese participants (i.e. the extracted differential correlation coefficients of the right hippocampus). Partial correlation plot on the right shows significant correlation between visceral adipose tissue and the intranasal insulin induced change in functional connectivity between dorsal medial PFC and hippocampus adjusted for total intracranial volume, sex, age and BMI (p&#x02009;&#x0003c;&#x02009;0.001, r<sub>adj</sub>&#x02009;=&#x02009;0.529). Circles represent lean participants and squares represent overweight and obese participants.</p></caption><graphic xlink:href="41598_2017_1907_Fig3_HTML" id="d29e560"/></fig>
</p><p>Mediation analyses was performed to test whether the increase in FC between the dorsal medial PFC and the hippocampus induced by intranasal insulin served as a mediator between abdominal fat (i.e. VAT) and hunger. This analysis revealed a significant negative indirect effect of VAT on hunger 120&#x02009;min after intranasal insulin application via the dorsal medial PFC-hippocampus functional connectivity change (standardized indirect effect <italic>ab</italic>&#x02009;=&#x02009;&#x02212;0.34, 95% Bootstrap CI &#x02212;6.54 to &#x02212;1.23; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). In other words, the increase in functional connectivity induced by intranasal insulin suppressed the relationship between VAT and hunger. No such relationship was observed on the placebo day.</p></sec><sec id="Sec4"><title>Insulin-induced changes in functional connectivity between the default-mode network and the hypothalamus</title><p>We observed a significant interaction between condition (insulin versus placebo) and peripheral insulin sensitivity in the hypothalamus (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Insulin increased functional connectivity after intranasal application compared to placebo between the anterior medial PFC and the hypothalamus (F&#x02009;=&#x02009;10.84; p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected; MNI coordinates x: &#x02212;6 y: 0 z: &#x02212;9) only in participants with high peripheral insulin sensitivity. The change in hypothalamic FC after insulin spray application significantly correlated positively with peripheral insulin sensitivity (T&#x02009;=&#x02009;3.3, p&#x02009;=&#x02009;0.002; r&#x02009;=&#x02009;0.476; r<sub>adj</sub>&#x02009;=&#x02009;0.459, adjusted for VAT, age, sex, and TICV) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). No such relationship was observed on placebo day.<fig id="Fig4"><label>Figure 4</label><caption><p>Model of visceral adipose tissue (VAT) as a predictor of subjective feeling of hunger mediated by functional connectivity change after insulin spray application. There is a significant indirect effect of VAT on the change of hunger via the change in functional connectivity between the dorsal medial prefrontal cortex and hippocampus 120&#x02009;min after insulin. Path coefficients and corresponding p-values are shown next to arrows; path a indicates the relationship between VAT and insulin-induced hippocampus functional connectivity change, path b indicates the relationship between the insulin-induced hippocampus functional connectivity change and change in hunger; path ab indicates the indirect effect of VAT on hunger via the insulin-induced hippocampus functional connectivity change; path c&#x02019; indicate the direct effect of VAT on the change in hunger after insulin.</p></caption><graphic xlink:href="41598_2017_1907_Fig4_HTML" id="d29e595"/></fig>
<fig id="Fig5"><label>Figure 5</label><caption><p>Intranasal insulin increases functional connectivity (FC) between the hypothalamus and the anterior medial prefrontal region of the default-mode network in peripherally insulin sensitive participants. Group-averaged DMN of lean and overweight/obese participants under baseline condition (rs<italic>fMRI1</italic>) for the anterior medial prefrontal cortex (PFC) seed region is displayed in red (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05, whole-brain corrected). Bright green color-coded region reveals voxels within the hypothalamus showing a significant change in functional connectivity with the anterior medial PFC of the DMN, as identified by a significant interaction between condition (insulin versus placebo spray) and the peripheral insulin sensitivity index (p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 small volume corrected). Partial correlation plot on the right shows a significant positive correlation between peripheral insulin sensitivity index and the change in functional connectivity between the anterior medial PFC and hypothalamus. With higher peripheral insulin sensitivity, we observed a stronger increase in functional connectivity adjusted for total intracranial volume, sex, age and visceral adipose tissue (r<sub>adj</sub>&#x02009;=&#x02009;0.459, p&#x02009;=&#x02009;0.002). Circles represent lean participants and squares represent overweight and obese participants. No such relationship was observed after placebo administration.</p></caption><graphic xlink:href="41598_2017_1907_Fig5_HTML" id="d29e618"/></fig>
</p></sec></sec><sec id="Sec5" sec-type="discussion"><title>Discussion</title><p>In healthy young lean, but also in overweight and obese participants, intranasal insulin acutely enhanced functional connectivity between the prefrontal regions of the DMN and the hippocampus. These regions are known to be crucial for higher cognitive processes. Interestingly, we found increased dorsal medial PFC-hippocampal functional connectivity to significantly modulate hunger. This insulin-induced increase acted as a mediator between individual&#x02019;s visceral adipose tissue, a metabolic unfavorable abdominal fat depot, and subjective feeling of hunger. Participants with a stronger increase in functional connectivity felt less hungry 120&#x02009;minutes after insulin administration. Furthermore, individuals with more visceral adipose tissue were hungrier. This relationship was suppressed by the increase in functional connectivity between the dorsal medial PFC and hippocampus. Moreover, the connection between metabolic and cognitive centers of the brain could be boosted by intranasal insulin, however only in participants with high peripheral insulin sensitivity. The higher the peripheral insulin sensitivity index, the stronger the increase in functional connectivity between the anterior medial prefrontal cortex of the DMN and the hypothalamus after insulin administration.</p><p>Neuroimaging studies investigating target brain regions of insulin action, using endogenous and exogenous stimulation of insulin, have identified the hypothalamus, striatal and frontal regions to be particularly insulin sensitive<sup><xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref></sup>. Specifically, in response to glucose ingestion, individuals with a higher increase in endogenous insulin showed a more pronounced prefrontal cortex activity decrease to food cues<sup><xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref></sup>. Similarly, the PFC and hypothalamus neural activity attenuated in response to intranasal insulin<sup><xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR39">39</xref></sup>. Moreover, not just localized neural activation but also functional connectivity of the hypothalamus and PFC can be modulated by glucose<sup><xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref></sup> or by meal ingestion<sup><xref ref-type="bibr" rid="CR45">45</xref>&#x02013;<xref ref-type="bibr" rid="CR47">47</xref></sup>. In the fasting compared to the fed state<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> hypothalamic-PFC functional connectivity was enhanced, while the ingestion of a meal reduced functional connectivity to the medial and lateral PFC<sup><xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR47">47</xref></sup>. Interestingly, other hormonal interventions with leptin<sup><xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref></sup> or intranasal oxytocin<sup><xref ref-type="bibr" rid="CR50">50</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref></sup> have likewise shown to alter PFC functional connectivity. Leptin replacement therapy in patients with lipodystrophy, for example, significantly increased hypothalamic-PFC functional connectivity accompanied by normalization of eating behavior<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Accordingly, in the current study we found the functional connection between the anterior medial PFC and the hypothalamus to increase in participants with favorable peripheral insulin sensitivity. Hence, evidence accumulates that brain-periphery interactions play an important role in the regulation of eating behavior and metabolism. With respect to insulin action, recent studies have shown that the prefrontal and hypothalamic response to insulin stimulation are significantly correlated with peripheral insulin sensitivity<sup><xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR42">42</xref></sup>. Moreover, intranasal insulin delivery to the brain improved peripheral insulin sensitivity in placebo-controlled hyperinsulinemic-euglycemic glucose clamps<sup><xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR53">53</xref></sup>. This coincides with the current finding that central insulin administration can enhance the functional connectivity between cognitive and homeostatic brain centers in peripherally insulin sensitive individuals.</p><p>The insulin-induced heightened functional connectivity between the prefrontal regions of the DMN and the hippocampus was independent of peripheral IR. Lean, overweight and obese participants with poor and high peripheral insulin sensitivity showed an increase in functional connectivity after intranasal insulin administration. Consistent with this notion, Fadel and Reagan<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> proposed that hippocampal IR may occur independent of peripheral IR. Rats with hippocampal-specific IR showed no changes in body weight and peripheral insulin sensitivity, however changes in neural plasticity and impaired spatial learning<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Interestingly, in the current study, we observed a link between central insulin action in the hippocampus and metabolism and hunger. The increased hippocampal functional connectivity acted as a mediator between perceived hunger and visceral adipose tissue. This is in line with animal and humans studies showing that the hippocampus processes visceral energy-status relevant information detecting interoceptive signals of hunger and satiety<sup><xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref></sup>. Hippocampal neurons form memory of a meal and are involved in inhibitory effects of recent eating on subsequent food consumption<sup><xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref></sup>. Concomitantly, patients with hippocampal lesions will rate their subjective state of hunger in the middle of the magnitude scale independent of when the last meal was consumed<sup><xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR58">58</xref></sup>. Moreover, reduced sensitivity to internal signals is found in obesity<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> and in individuals with high western diet consumption<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Specifically participants with self-reported high fat and high refined-sugar diet performed poorer on hippocampal sensitive memory tasks and were less accurate in recalling what they had previously eaten<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Free-fatty acids (FFAs), which can be mildly suppressed by intranasal insulin<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, may mediate the relationship between visceral adipose tissue and brain insulin responsiveness. Specifically, elevated levels of saturated nonesterified fatty acids led to a diminished insulin reactivity in theta frequency activity generated in the hippocampus<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Hence, it is possible that circulating FFAs in individuals with high visceral adipose tissue interferes with the subjective feeling of hunger. Enhancing hippocampal functional connectivity by means of centrally acting insulin could potentially breach this viscous cycle improving internal awareness for hunger. Hence, we propose that the beneficial effects of boosting hippocampal functional connectivity with intranasal insulin go beyond improving cognition, as recently reported<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. It can potentially improve metabolism by enhancing the sensitivity to internal signals, thereby reducing perceived hunger. Hence, intranasal insulin could be a potential therapeutic tool to improve memory formation for food and raise internal awareness for satiety and hunger signals.</p><p>While solid evidence exists that obesity-associated IR affects at least parts of the DMN<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, the current study showed for the first time that DMN functional connectivity plays a pivotal role in central insulin action in cognitively healthy young adults. The prefrontal part of the DMN, in particular, may constitute a link between networks controlling insulin-mediated effects on metabolism and cognition. However, besides brain IR, peripheral IR seems to play an important role in DMN function. Even in cognitively intact prediabetes and T2D patients, the severity of peripheral IR is related to altered brain function in regions of the DMN showing reduced cerebral blood flow and disrupted functional connectivity<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Interestingly, treated T2D patients do not show reduced cerebral blood flow in the DMN compared to the insulin resistant controls<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Hence, it could be that altered brain functions in regions of the DMN is a consequence of peripheral IR rather than a cause of brain IR. Concurrently, we identified obesity-associated changes in functional connectivity in the posterior part of the DMN, which was not influenced by intranasal insulin. Hence, we propose the anterior part of the DMN to constitute an overlap between peripheral and central IR. However, further studies are necessary to investigate cause and consequences of central and peripheral IR.</p><p>A limitation of the study is the missing examinations on cognitive functions. All of our participants were students at the university and displayed no psychiatric or neurological illness. Furthermore, we used a thorough metabolic screening to exclude type 2 diabetes and other alterations associated with the metabolic syndrome. Nonetheless, to further link metabolic and cognitive endpoints of brain insulin action, further studies are necessary evaluating metabolism as well as cognition. Moreover, we cannot rule out a possible spillover of intranasal insulin into the peripheral blood<sup><xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR65">65</xref></sup>. More frequent blood sampling is needed to detect this phenomenon. We recently characterized this spillover at systemic elevated insulin levels. Even after mimicking the spillover effect during the placebo condition, intranasal insulin still significantly mediated whole-body metabolism<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. However, no detailed kinetics have yet been reported at fasting insulin levels.</p><p>Taken together, we were able to show that acute administration of intranasal insulin administration can enhance DMN functional connectivity in healthy lean, overweight and obese adults. The insulin induced increase in dorsal medial PFC-hippocampal functional connectivity served as a mediator, suppressing the relationship between visceral adipose tissue and hunger. Furthermore, we observed a significant brain-periphery interaction of insulin action. Only individuals with an insulin-induced DMN-hypothalamic functional connectivity change revealed favorable peripheral insulin sensitivity. Therefore, enhancing brain functional connectivity using intranasal insulin has potential to boost cognition and metabolism. The relevance of our findings for the treatment of obesity and metabolic disease is currently however still speculative. Our results point to a novel mechanism of how brain insulin action facilitates weight loss by enhancing brain functional connectivity and reducing perceived hunger. Hence, intranasal insulin could be a potential therapeutic tool to improve internal awareness for satiety and hunger signals. Further intervention studies have to be conducted to demonstrate who will benefit from enhancing brain insulin action.</p></sec><sec id="Sec6" sec-type="materials|methods"><title>Methods</title><sec id="Sec7"><title>Participants</title><p>The study sample consisted of 25 healthy lean and 10 overweight and 12 obese adult participants (BMI range 19&#x02013;40&#x02009;kg/m<sup>2</sup>), who were also part of a recent study investigating brain insulin action using cerebral blood flow<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Overweight and obese participants were required to have a BMI greater than 25&#x02009;kg/m&#x000b2;. One obese subject could not be analyzed due to missing functional MRI data. The Ethics Committee of the Medical Faculty at the University of T&#x000fc;bingen approved the protocol and informed written consent was obtained from all participants. All participants were students at the University of T&#x000fc;bingen recruited using broadcast emails. The study was registered as clinical trial (NCT01797601; February 18<sup>th</sup> 2013). To assure that participants were healthy and did not suffer from psychiatric, neurological nor metabolic diseases, they underwent a thorough medical examination. To assess body fat distribution of the participants, whole-body MRI measurements were obtained at a 1.5-T whole body imager (Magnetom Sonata; Siemens Healthcare, Erlangen, Germany) (for further description please see Kullmann <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>). To assess peripheral insulin sensitivity, all participants underwent a 75&#x02009;g oral glucose tolerance test with blood drawing at five time points after an overnight fast prior to the intranasal experiment. Insulin sensitivity was estimated according to Matsuda and DeFronzo<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. The study was performed in accordance with the relevant guidelines and regulations. Participants characteristics are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Participants&#x02019; characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Lean group</th><th>Overweight/Obese group</th><th>p</th></tr></thead><tbody><tr><td>Gender (female/male)</td><td>10/15</td><td>11/11</td><td>&#x02014;</td></tr><tr><td>Age (y)</td><td>25.88&#x02009;&#x000b1;&#x02009;3.30</td><td>26.81&#x02009;&#x000b1;&#x02009;3.62</td><td>0.360</td></tr><tr><td>Body mass index (kg/m&#x000b2;)</td><td>22.59&#x02009;&#x000b1;&#x02009;1.99</td><td>30.57&#x02009;&#x000b1;&#x02009;3.51</td><td>&#x0003c;0.001</td></tr><tr><td>oGTT-derived insulin sensitivity index (AU)</td><td>16.0&#x02009;&#x000b1;&#x02009;7.6</td><td>10.66&#x02009;&#x000b1;&#x02009;6.56</td><td>0.005</td></tr><tr><td>HbA1c (% and mmol/mol)</td><td>5.2&#x02009;&#x000b1;&#x02009;0.3/33.15&#x02009;&#x000b1;&#x02009;3.1</td><td>5.3&#x02009;&#x000b1;&#x02009;0.3/33.9&#x02009;&#x000b1;&#x02009;2.7</td><td>0.380</td></tr><tr><td colspan="4">Whole-body MRI (in liter)</td></tr><tr><td>&#x000a0;Total adipose tissue</td><td>17.82&#x02009;&#x000b1;&#x02009;4.41</td><td>40.5&#x02009;&#x000b1;&#x02009;10.7</td><td>&#x0003c;0.001</td></tr><tr><td>&#x000a0;Visceral adipose tissue</td><td>1.55&#x02009;&#x000b1;&#x02009;0.86</td><td>3.18&#x02009;&#x000b1;&#x02009;1.48</td><td>&#x0003c;0.001</td></tr><tr><td>&#x000a0;Subcutaneous adipose tissue</td><td>4.87&#x02009;&#x000b1;&#x02009;1.69</td><td>14.55&#x02009;&#x000b1;&#x02009;4.6</td><td>&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean&#x02009;&#x000b1;&#x02009;SD. P&#x02009;=&#x02009;P-values for comparison of unadjusted log<sub><italic>e</italic></sub>-transformed data by ANOVA.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec8"><title>Study design</title><p>Intranasal insulin and placebo was administered on two separate study days (time-lag of 7&#x02013;14 days) and fMRI was recorded. Studies were conducted after an overnight fast of at least 10&#x02009;hours and started at 7.00 a.m. with a resting-state fMRI measurement under basal conditions (rsfMRI 1). After the basal measurement, an insulin/placebo spray was administered intranasally as described below. After 30&#x02009;minutes, a second resting-state fMRI measurement was performed (rsfMRI 2).</p><p>Subjective feeling of hunger was rated at three time points (before spray application, 60 and 120&#x02009;min after intranasal spray) on a visual analogue scale from 0 to 10 (0: not hungry at all; 10: very hungry) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Venous blood samples were obtained at different time point (for details see Kullmann <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>).</p></sec><sec id="Sec9"><title>Application intranasal insulin/placebo</title><p>The insulin and placebo spray were prepared in nasal sprays. In a randomized fashion, participants received on one day 160 U of insulin (Insulin Actrapid; Novo Nordisk, Bagsvaerd, Denmark) and on the other measurement day vehicle as placebo. Participants were single-blinded to the order of the conditions.</p></sec><sec id="Sec10"><title>Whole-brain fMRI Measurement</title><sec id="Sec11"><title>Data acquisition</title><p>Whole-brain fMRI data was obtained by using a 3.0 T scanner using a 12-channel head coil (Siemens Tim Trio, Erlangen, Germany). Functional data were collected by using gradient echo echo-planar imaging (GE-EPI) sequences. All participants were instructed not to focus their thoughts on anything in particular and to keep their eyes closed during the resting state fMRI acquisition. The following sequence was used: TR&#x02009;=&#x02009;2&#x02009;s, TE&#x02009;=&#x02009;30&#x02009;ms, FOV&#x02009;=&#x02009;210&#x02009;mm&#x000b2;,matrix 64&#x02009;&#x000d7;&#x02009;64, flip angle 90&#x000b0;, voxel size 3&#x02009;&#x000d7;&#x02009;3&#x02009;&#x000d7;&#x02009;3.6&#x02009;mm<sup>3</sup>, slice thickness 3.6&#x02009;mm, images were acquired in ascending order. Each brain volume comprised 26 axial slices and each functional run contained 176 image volumes, resulting in a total scan time of 6:04&#x02009;minutes. In addition, high-resolution T1 weighted anatomical images (MPRage: 192 slices, matrix: 256&#x02009;&#x000d7;&#x02009;240, 1&#x02009;&#x000d7;&#x02009;1&#x02009;&#x000d7;&#x02009;1&#x02009;mm<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>) of the brain were obtained.</p></sec><sec id="Sec12"><title>Resting-state fMRI Data processing</title><p>We used the Data Processing Assistant for Resting-State fMRI (DPARSF)<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://www.restfmri.net">http://www.restfmri.net</ext-link>) to analyze the resting state fMRI data. DPRSF is based on Statistical Parametric Mapping (SPM8) (<ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm">http://www.fil.ion.ucl.ac.uk/spm</ext-link>) and Resting-State fMRI Data Analysis Toolkit<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> (REST, <ext-link ext-link-type="uri" xlink:href="http://www.restfmri.net">http://www.restfmri.net</ext-link>). The functional images were realigned and co-registered to the T1 structural image. The anatomical image was normalized to the Montreal Neurological Institute (MNI) template using DARTEL, and the resulting parameter file was used to normalize the functional images (voxel size: 3&#x02009;&#x000d7;&#x02009;3&#x02009;&#x000d7;&#x02009;3&#x02009;mm). Finally, the normalized images were smoothed with a three-dimensional isotropic Gaussian kernel (FWHM: 6&#x02009;mm). A temporal filter (0.01~0.08&#x02009;Hz) was applied to reduce low frequency drifts and high frequency physiological noise. Nuisance regression was performed using white matter, CSF, and the six head motion parameters as covariates. No participant had head motion with more than 2.0&#x02009;mm maximum displacement or 2.0&#x000b0; of any angular motion.</p></sec><sec id="Sec13"><title>Resting-state functional connectivity analyses</title><p>Functional connectivity (FC) maps were obtained using a seed-based voxel wise correlation approach by computing FC between a seed region and each voxel within the brain. We defined four seed regions according to Andrews-Hanna <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>: the core region of the DMN and three prefrontal regions of DMN (seed 1: posterior cingulate/precuneus x: &#x02212;8 y: &#x02212;56 z: 26; seed 2: anterior medial prefrontal cortex x:&#x02212;6 y: 52 z: &#x02212;2; seed 3: dorsal medial prefrontal cortex x: 0 y: 52 z: 26 and seed 4: ventromedial prefrontal cortex x: 0 y: 26 z: &#x02212;18 (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). All seed regions included a 5&#x02009;mm sphere. The FC maps were transferred to z values using Fisher&#x02019;s transformation<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. For further statistical analysis, FC maps of rs<italic>fMRI2</italic> were subtracted from rs<italic>fMRI1</italic> for both placebo and insulin day. Changes in FC 30&#x02009;min after insulin versus placebo administration were analyzed in SPM8 using a full-factorial model (between group factor: lean and obese; within-group factor: insulin and placebo, covariate: oGTT-derived peripheral insulin sensitivity index). A statistical threshold of p<sub>FWE</sub>&#x02009;&#x0003c;&#x02009;0.05 voxel-level whole-brain corrected was applied. Additionally, small volume correction was performed for the hypothalamus and the hippocampus, as they are <italic>a priori</italic> regions of interest. The hypothalamus and hippocampus masks were based on the <italic>wfu</italic> pick atlas (<ext-link ext-link-type="uri" xlink:href="http://fmri.wfubmc.edu/software/PickAtlas">http://fmri.wfubmc.edu/software/PickAtlas</ext-link>).</p><p>Functional connectivity values (z-transformed correlation coefficients) of regions showing significant change in FC after insulin administration were extracted for further statistical analyses in SPSS (version 20, IBM, Armonk, USA). We evaluated whether changes in FC show a significant relationship with the subjective feeling of hunger after insulin spray application, with peripheral insulin sensitivity, BMI and with different fat compartments as evaluated with T1-weighted whole-body MRI data (visceral adipose tissue (VAT), subcutaneous adipose tissue (SCAT) and total adipose tissue (TAT))<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> using a multiple regression analyses. All regressions included age, total intracranial volume (TICV) and sex as confounding regressors. An adjusted statistical threshold of p&#x02009;&#x02264;&#x02009;0.002 correcting for number of tests (n&#x02009;=&#x02009;25) was used.</p><p>Mediation analyses of the relationship between VAT, hunger and extracted FC change between dorsal medial PFC and hippocampus was performed using PROCESS version 2.15 procedure in SPSS (<ext-link ext-link-type="uri" xlink:href="http://www.afhayes.com">www.afhayes.com</ext-link>). The concept of a mediation analysis works as follows. The relationship between a predictor (x) and an outcome variable (y) can be explained by their relationship to a third variable (the mediator (m)). The predictor (x) predicts the mediator (m) through the path denoted by path <bold><italic>a</italic></bold>. The mediator (m) predicts the outcome (y) through the outcome denoted by path <bold><italic>b</italic></bold>. The relationship between predictor and outcome controlling for the mediator in the model is denoted as direct effect i.e. path c&#x02019;. The total effect is the effect of the predictor on the outcome when the mediator is not present in the model (i.e. path c). The effect of mediation is investigated through the indirect effect, which is a cross product of <bold><italic>a</italic></bold> and <bold><italic>b</italic></bold>
<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. The mediation model included VAT as the predictor (<bold>x</bold>), change in hunger rating as the outcome variable (<bold>y</bold>) and change in FC between dorsal medial PFC and hippocampus as the mediator (<bold>m</bold>). Additional covariates were added to the model for adjustments (covariates: BMI, age, sex and TICV). The significance of the mediation analysis (i.e. indirect effect <bold><italic>ab</italic></bold>) was estimated based on a bias-corrected bootstrap confidence interval (CI 95%, 10 000 bootstrap samples). If the confidence interval does not contain zero then the &#x02018;true effect&#x02019; size is different from &#x02018;no effect&#x02019;. This means there is a significant mediation. Furthermore, we report a standardized indirect effect measure to ensure comparability with other studies<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>.</p></sec></sec></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec14"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_1907_MOESM1_ESM.pdf"><caption><p>Supplementary Figures</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>
<bold>Supplementary information</bold> accompanies this paper at doi:10.1038/s41598-017-01907-w
</p></fn><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The study was supported in part by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), by the Helmholtz Alliance ICEMED - <italic>Imaging and Curing Environmental Metabolic Diseases</italic>, through the Initiative and Network Fund of the Helmholtz Association, by grants from the German Diabetes Foundation (DDG) to M.H. and S.K (DDG and DDS 309/01/12), and by the European Union Seventh Framework Programme (FP7/2007&#x02013;2013) under Grant Agreement 607310 (Nudge-it). The funding sources were not involved in the study design, data collection analysis and interpretation of the data.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>S.K. designed study, ran experiment, analyzed and interpreted the data and wrote manuscript. M.H. designed study; interpreted data gave input for writing manuscript. R.V. assisted S.K. in fMRI data analysis. K.S. designed study and gave input for writing manuscript. J.M. responsible for whole-body MRI data collection and data entry. A.F., H.H. and H.P. designed study interpreted data gave input for writing manuscript. All authors declare no conflict of interest.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Dickson, S. L. &#x00026; Mercer, J. G. <italic>Neuroendocrinology of Appetite</italic>. First edn, 296 (John Wiley &#x00026; Sons, 2016).</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>KW</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name></person-group><article-title>From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior</article-title><source>Nat Neurosci</source><year>2012</year><volume>15</volume><fpage>1350</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1038/nn.3217</pub-id><pub-id pub-id-type="pmid">23007190</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckel</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction</article-title><source>F1000Research</source><year>2016</year><volume>5</volume><fpage>353</fpage><pub-id pub-id-type="pmid">27303627</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kullmann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans</article-title><source>Physiol Rev</source><year>2016</year><volume>96</volume><fpage>1169</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1152/physrev.00032.2015</pub-id><pub-id pub-id-type="pmid">27489306</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinridders</surname><given-names>A</given-names></name><name><surname>Ferris</surname><given-names>HA</given-names></name><name><surname>Cai</surname><given-names>W</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name></person-group><article-title>Insulin action in brain regulates systemic metabolism and brain function</article-title><source>Diabetes</source><year>2014</year><volume>63</volume><fpage>2232</fpage><lpage>2243</lpage><pub-id pub-id-type="doi">10.2337/db14-0568</pub-id><pub-id pub-id-type="pmid">24931034</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lochhead</surname><given-names>JJ</given-names></name><name><surname>Thorne</surname><given-names>RG</given-names></name></person-group><article-title>Intranasal delivery of biologics to the central nervous system</article-title><source>Advanced drug delivery reviews</source><year>2012</year><volume>64</volume><fpage>614</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2011.11.002</pub-id><pub-id pub-id-type="pmid">22119441</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Kullmann, S., Heni, M., Fritsche, A. &#x00026; Preissl, H. Insulin action in the human brain: evidence from neuroimaging studies. <italic>J Neuroendocrinol</italic> (2015).</mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Heni, M., Kullmann, S., Preissl, H., Fritsche, A. &#x00026; Haring, H. U. Impaired insulin action in the human brain: causes and metabolic consequences. <italic>Nat Rev Endocrinol</italic> (2015).</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname><given-names>V</given-names></name><name><surname>Benedict</surname><given-names>C</given-names></name><name><surname>Schultes</surname><given-names>B</given-names></name><name><surname>Born</surname><given-names>J</given-names></name><name><surname>Hallschmid</surname><given-names>M</given-names></name></person-group><article-title>Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism</article-title><source>Diabetes Obes Metab</source><year>2012</year><volume>14</volume><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1111/j.1463-1326.2011.01490.x</pub-id><pub-id pub-id-type="pmid">21883804</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedict</surname><given-names>C</given-names></name><name><surname>Kern</surname><given-names>W</given-names></name><name><surname>Schultes</surname><given-names>B</given-names></name><name><surname>Born</surname><given-names>J</given-names></name><name><surname>Hallschmid</surname><given-names>M</given-names></name></person-group><article-title>Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin</article-title><source>J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><fpage>1339</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-2606</pub-id><pub-id pub-id-type="pmid">18230654</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Kullmann, S. <italic>et al</italic>. Selective Insulin Resistance in Homeostatic and Cognitive Control Brain Areas in Overweight and Obese Adults. <italic>Diabetes Care</italic> (2015).</mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Hallschmid, M., Higgs, S., Thienel, M., Ott, V. &#x00026; Lehnert, H. Postprandial Administration of Intranasal Insulin Intensifies Satiety and Reduces Intake of Palatable Snacks in Women. <italic>Diabetes</italic> (2012).</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Rodriguez-Raecke, R., Yang, H., Brunner, Y. F. &#x00026; Freiherr, J. Intranasal insulin boosts gustatory sensitivity. <italic>J Neuroendocrinol</italic> (2016).</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner</surname><given-names>YF</given-names></name><name><surname>Benedict</surname><given-names>C</given-names></name><name><surname>Freiherr</surname><given-names>J</given-names></name></person-group><article-title>Intranasal insulin reduces olfactory sensitivity in normosmic humans</article-title><source>J Clin Endocrinol Metab</source><year>2013</year><volume>98</volume><fpage>E1626</fpage><lpage>1630</lpage><pub-id pub-id-type="doi">10.1210/jc.2013-2061</pub-id><pub-id pub-id-type="pmid">23928664</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heni</surname><given-names>M</given-names></name><etal/></person-group><article-title>Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men</article-title><source>Diabetes</source><year>2014</year><volume>63</volume><fpage>4083</fpage><lpage>4088</lpage><pub-id pub-id-type="doi">10.2337/db14-0477</pub-id><pub-id pub-id-type="pmid">25028522</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Air</surname><given-names>EL</given-names></name><name><surname>Benoit</surname><given-names>SC</given-names></name><name><surname>Blake Smith</surname><given-names>KA</given-names></name><name><surname>Clegg</surname><given-names>DJ</given-names></name><name><surname>Woods</surname><given-names>SC</given-names></name></person-group><article-title>Acute third ventricular administration of insulin decreases food intake in two paradigms</article-title><source>Pharmacol Biochem Behav</source><year>2002</year><volume>72</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(01)00780-8</pub-id><pub-id pub-id-type="pmid">11900815</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>H</given-names></name><etal/></person-group><article-title>Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats</article-title><source>Appetite</source><year>1986</year><volume>7</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/S0195-6663(86)80006-X</pub-id><pub-id pub-id-type="pmid">3539015</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>LM</given-names></name><name><surname>Clegg</surname><given-names>DJ</given-names></name><name><surname>Benoit</surname><given-names>SC</given-names></name><name><surname>Woods</surname><given-names>SC</given-names></name></person-group><article-title>Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6&#x02009;J mice</article-title><source>Physiol Behav</source><year>2006</year><volume>89</volume><fpage>687</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2006.08.008</pub-id><pub-id pub-id-type="pmid">16979194</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedict</surname><given-names>C</given-names></name><etal/></person-group><article-title>Intranasal insulin improves memory in humans</article-title><source>Psychoneuroendocrinology</source><year>2004</year><volume>29</volume><fpage>1326</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2004.04.003</pub-id><pub-id pub-id-type="pmid">15288712</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claxton</surname><given-names>A</given-names></name><etal/></person-group><article-title>Long Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer&#x02019;s Disease Dementia</article-title><source>J Alzheimers Dis</source><year>2015</year><volume>45</volume><fpage>1269</fpage><lpage>1270</lpage><pub-id pub-id-type="pmid">25869922</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claxton</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer&#x02019;s disease</article-title><source>J Alzheimers Dis</source><year>2013</year><volume>35</volume><fpage>789</fpage><lpage>797</lpage><pub-id pub-id-type="pmid">23507773</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craft</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial</article-title><source>Arch Neurol</source><year>2012</year><volume>69</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2011.233</pub-id><pub-id pub-id-type="pmid">21911655</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>V</given-names></name><etal/></person-group><article-title>Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes</article-title><source>Diabetes Care</source><year>2014</year><volume>37</volume><fpage>751</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.2337/dc13-1672</pub-id><pub-id pub-id-type="pmid">24101698</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner</surname><given-names>YF</given-names></name><name><surname>Kofoet</surname><given-names>A</given-names></name><name><surname>Benedict</surname><given-names>C</given-names></name><name><surname>Freiherr</surname><given-names>J</given-names></name></person-group><article-title>Central insulin administration improves odor-cued reactivation of spatial memory in young men</article-title><source>J Clin Endocrinol Metab</source><year>2015</year><volume>100</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1210/jc.2014-3018</pub-id><pub-id pub-id-type="pmid">25337926</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadel</surname><given-names>JR</given-names></name><name><surname>Reagan</surname><given-names>LP</given-names></name></person-group><article-title>Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits</article-title><source>Current opinion in behavioral sciences</source><year>2016</year><volume>9</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.cobeha.2015.12.004</pub-id><pub-id pub-id-type="pmid">26955646</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biessels</surname><given-names>GJ</given-names></name><name><surname>Reagan</surname><given-names>LP</given-names></name></person-group><article-title>Hippocampal insulin resistance and cognitive dysfunction</article-title><source>Nat Rev Neurosci</source><year>2015</year><volume>16</volume><fpage>660</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1038/nrn4019</pub-id><pub-id pub-id-type="pmid">26462756</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Dhamoon, M. S., Noble, J. M. &#x00026; Craft, S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. <italic>Neurology</italic><bold>72</bold>, 292-293; author reply 293-294 (2009).</mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reger</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype</article-title><source>Neurobiol Aging</source><year>2006</year><volume>27</volume><fpage>451</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.03.016</pub-id><pub-id pub-id-type="pmid">15964100</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reger</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults</article-title><source>J Alzheimers Dis</source><year>2008</year><volume>13</volume><fpage>323</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.3233/JAD-2008-13309</pub-id><pub-id pub-id-type="pmid">18430999</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reger</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Intranasal insulin improves cognition and modulates beta-amyloid in early AD</article-title><source>Neurology</source><year>2008</year><volume>70</volume><fpage>440</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1212/01.WNL.0000265401.62434.36</pub-id><pub-id pub-id-type="pmid">17942819</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>1025</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.2337/db14-1000</pub-id><pub-id pub-id-type="pmid">25249577</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>A</given-names></name><etal/></person-group><article-title>The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review</article-title><source>Yale J Biol Med</source><year>2016</year><volume>89</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">27505016</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musen</surname><given-names>G</given-names></name><etal/></person-group><article-title>Resting-state brain functional connectivity is altered in type 2 diabetes</article-title><source>Diabetes</source><year>2012</year><volume>61</volume><fpage>2375</fpage><lpage>2379</lpage><pub-id pub-id-type="doi">10.2337/db11-1669</pub-id><pub-id pub-id-type="pmid">22664957</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>W</given-names></name><etal/></person-group><article-title>Insulin Resistance-Associated Interhemispheric Functional Connectivity Alterations in T2DM: A Resting-State fMRI Study</article-title><source>BioMed research international</source><year>2015</year><volume>2015</volume><fpage>719076</fpage><pub-id pub-id-type="pmid">26064945</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kullmann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Specific white matter tissue microstructure changes associated with obesity</article-title><source>Neuroimage</source><year>2016</year><volume>125</volume><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.10.006</pub-id><pub-id pub-id-type="pmid">26458514</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kullmann</surname><given-names>S</given-names></name><etal/></person-group><article-title>The obese brain: Association of body mass index and insulin sensitivity with resting state network functional connectivity</article-title><source>Hum Brain Mapp</source><year>2012</year><volume>33</volume><fpage>1052</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1002/hbm.21268</pub-id><pub-id pub-id-type="pmid">21520345</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heni</surname><given-names>M</given-names></name><etal/></person-group><article-title>Differential effect of glucose ingestion on the neural processing of food stimuli in lean and overweight adults</article-title><source>Hum Brain Mapp</source><year>2013</year><volume>35</volume><fpage>918</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1002/hbm.22223</pub-id><pub-id pub-id-type="pmid">23307469</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kullmann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women</article-title><source>Neuroendocrinology</source><year>2013</year><volume>97</volume><fpage>176</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1159/000341406</pub-id><pub-id pub-id-type="pmid">22922661</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heni</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><fpage>1773</fpage><lpage>1782</lpage><pub-id pub-id-type="doi">10.1007/s00125-012-2528-y</pub-id><pub-id pub-id-type="pmid">22434537</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kullmann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Resting-state functional connectivity of the human hypothalamus</article-title><source>Hum Brain Mapp</source><year>2014</year><volume>35</volume><fpage>6088</fpage><lpage>6096</lpage><pub-id pub-id-type="doi">10.1002/hbm.22607</pub-id><pub-id pub-id-type="pmid">25131690</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschritter</surname><given-names>O</given-names></name><etal/></person-group><article-title>The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>12103</fpage><lpage>12108</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604404103</pub-id><pub-id pub-id-type="pmid">16877540</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Kroemer, N. B. <italic>et al</italic>. (Still) longing for food: Insulin reactivity modulates response to food pictures. <italic>Hum Brain Mapp</italic> (2012).</mixed-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways</article-title><source>JAMA</source><year>2013</year><volume>309</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1001/jama.2012.116975</pub-id><pub-id pub-id-type="pmid">23280226</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jastreboff</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Altered Brain Response to Drinking Glucose and Fructose in Obese Adolescents</article-title><source>Diabetes</source><year>2016</year><volume>65</volume><fpage>1929</fpage><lpage>1939</lpage><pub-id pub-id-type="doi">10.2337/db15-1216</pub-id><pub-id pub-id-type="pmid">27207544</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Pribic, T. <italic>et al</italic>. Brain networks associated with cognitive and hedonic responses to a meal. <italic>Neurogastroenterol Motil</italic> (2017).</mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>H</given-names></name><etal/></person-group><article-title>Differential effects of hunger and satiety on insular cortex and hypothalamic functional connectivity</article-title><source>Eur J Neurosci</source><year>2016</year><volume>43</volume><fpage>1181</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1111/ejn.13182</pub-id><pub-id pub-id-type="pmid">26790868</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lips</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Resting-state functional connectivity of brain regions involved in cognitive control, motivation, and reward is enhanced in obese females</article-title><source>Am J Clin Nutr</source><year>2014</year><volume>100</volume><fpage>524</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.3945/ajcn.113.080671</pub-id><pub-id pub-id-type="pmid">24965310</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farr</surname><given-names>OM</given-names></name><etal/></person-group><article-title>Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure</article-title><source>J Clin Endocrinol Metab</source><year>2014</year><volume>99</volume><fpage>E2529</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1210/jc.2014-2774</pub-id><pub-id pub-id-type="pmid">25279500</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlogl</surname><given-names>H</given-names></name><etal/></person-group><article-title>Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior</article-title><source>Diabetes</source><year>2016</year><volume>65</volume><fpage>2179</fpage><lpage>2186</lpage><pub-id pub-id-type="doi">10.2337/db15-1550</pub-id><pub-id pub-id-type="pmid">27207511</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Eckstein, M. <italic>et al</italic>. Oxytocin differentially alters resting state functional connectivity between amygdala subregions and emotional control networks: inverse correlation with depressive traits. <italic>Neuroimage</italic> (2017).</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebner</surname><given-names>NC</given-names></name><etal/></person-group><article-title>Oxytocin&#x02019;s effect on resting-state functional connectivity varies by age and sex</article-title><source>Psychoneuroendocrinology</source><year>2016</year><volume>69</volume><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.03.013</pub-id><pub-id pub-id-type="pmid">27032063</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethlehem</surname><given-names>RA</given-names></name><name><surname>van Honk</surname><given-names>J</given-names></name><name><surname>Auyeung</surname><given-names>B</given-names></name><name><surname>Baron-Cohen</surname><given-names>S</given-names></name></person-group><article-title>Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies</article-title><source>Psychoneuroendocrinology</source><year>2013</year><volume>38</volume><fpage>962</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2012.10.011</pub-id><pub-id pub-id-type="pmid">23159011</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Heni, M. <italic>et al</italic>. Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but not in Overweight Men. <italic>Diabetes</italic> (2017).</mixed-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grillo</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>3927</fpage><lpage>3936</lpage><pub-id pub-id-type="doi">10.2337/db15-0596</pub-id><pub-id pub-id-type="pmid">26216852</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Kanoski, S. E. &#x00026; Grill, H. J. Hippocampus Contributions to Food Intake Control: Mnemonic, Neuroanatomical, and Endocrine Mechanisms. <italic>Biol Psychiatry</italic> (2015).</mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Coppin, G. The anterior medial temporal lobes: Their role in food intake and body weight regulation. <italic>Physiol Behav</italic> (2016).</mixed-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgs</surname><given-names>S</given-names></name></person-group><article-title>Cognitive processing of food rewards</article-title><source>Appetite</source><year>2016</year><volume>104</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.appet.2015.10.003</pub-id><pub-id pub-id-type="pmid">26458961</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgs</surname><given-names>S</given-names></name><name><surname>Williamson</surname><given-names>AC</given-names></name><name><surname>Rotshtein</surname><given-names>P</given-names></name><name><surname>Humphreys</surname><given-names>GW</given-names></name></person-group><article-title>Sensory-specific satiety is intact in amnesics who eat multiple meals</article-title><source>Psychol Sci</source><year>2008</year><volume>19</volume><fpage>623</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1111/j.1467-9280.2008.02132.x</pub-id><pub-id pub-id-type="pmid">18727773</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>BM</given-names></name><name><surname>Pollatos</surname><given-names>O</given-names></name></person-group><article-title>Attenuated interoceptive sensitivity in overweight and obese individuals</article-title><source>Eat Behav</source><year>2014</year><volume>15</volume><fpage>445</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.eatbeh.2014.06.002</pub-id><pub-id pub-id-type="pmid">25064297</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>HM</given-names></name><name><surname>Stevenson</surname><given-names>RJ</given-names></name></person-group><article-title>Higher reported saturated fat and refined sugar intake is associated with reduced hippocampal-dependent memory and sensitivity to interoceptive signals</article-title><source>Behav Neurosci</source><year>2011</year><volume>125</volume><fpage>943</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1037/a0025998</pub-id><pub-id pub-id-type="pmid">22023100</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwen</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans</article-title><source>J Clin Endocrinol Metab</source><year>2014</year><volume>99</volume><fpage>E246</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1210/jc.2013-3169</pub-id><pub-id pub-id-type="pmid">24423295</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschritter</surname><given-names>O</given-names></name><etal/></person-group><article-title>The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids</article-title><source>J Clin Endocrinol Metab</source><year>2009</year><volume>94</volume><fpage>4600</fpage><lpage>4607</lpage><pub-id pub-id-type="doi">10.1210/jc.2009-0469</pub-id><pub-id pub-id-type="pmid">19820026</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>LD</given-names></name><etal/></person-group><article-title>Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes</article-title><source>Arch Neurol</source><year>2011</year><volume>68</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2010.225</pub-id><pub-id pub-id-type="pmid">20837822</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusinek</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cerebral perfusion in insulin resistance and type 2 diabetes</article-title><source>J Cereb Blood Flow Metab</source><year>2015</year><volume>35</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1038/jcbfm.2014.173</pub-id><pub-id pub-id-type="pmid">25315860</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Morgantini</surname><given-names>C</given-names></name><name><surname>Koulajian</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>GF</given-names></name></person-group><article-title>Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations</article-title><source>Diabetes</source><year>2015</year><volume>64</volume><fpage>766</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.2337/db14-0685</pub-id><pub-id pub-id-type="pmid">25288674</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>DeFronzo</surname><given-names>RA</given-names></name></person-group><article-title>Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><fpage>1462</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.2337/diacare.22.9.1462</pub-id><pub-id pub-id-type="pmid">10480510</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao-Gan</surname><given-names>Y</given-names></name><name><surname>Yu-Feng</surname><given-names>Z</given-names></name></person-group><article-title>DPARSF: A MATLAB Toolbox for &#x0201c;Pipeline&#x0201d; Data Analysis of Resting-State fMRI</article-title><source>Front Syst Neurosci</source><year>2010</year><volume>4</volume><fpage>13</fpage><pub-id pub-id-type="pmid">20577591</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>XW</given-names></name><etal/></person-group><article-title>REST: a toolkit for resting-state functional magnetic resonance imaging data processing</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e25031</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025031</pub-id><pub-id pub-id-type="pmid">21949842</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews-Hanna</surname><given-names>JR</given-names></name><name><surname>Reidler</surname><given-names>JS</given-names></name><name><surname>Sepulcre</surname><given-names>J</given-names></name><name><surname>Poulin</surname><given-names>R</given-names></name><name><surname>Buckner</surname><given-names>RL</given-names></name></person-group><article-title>Functional-anatomic fractionation of the brain&#x02019;s default network</article-title><source>Neuron</source><year>2010</year><volume>65</volume><fpage>550</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.005</pub-id><pub-id pub-id-type="pmid">20188659</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machann</surname><given-names>J</given-names></name><etal/></person-group><article-title>Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes</article-title><source>Radiology</source><year>2010</year><volume>257</volume><fpage>353</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1148/radiol.10092284</pub-id><pub-id pub-id-type="pmid">20713612</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Field, A. <italic>Discovering Statistics Using IBM SPSS Statistics</italic>. 4 edn. (SAGE Publications Ltd, 2013).</mixed-citation></ref></ref-list></back></article>